The report entitled “The US Onychomycosis Market: Size, Trends & Forecasts (2019-2023 Edition)”, provides analysis of the US onychomycosis market, with detailed analysis of market size in terms of value, volume and segments. The report also includes the analysis of the larger nail care market in order to showcase the position of onychomycosis with respect to the nail care industry.
Get free sample copy of this report at https://www.marketreportsonline.com/contacts/requestsample.php?name=787782.
Under competitive landscape, different players in the onychomycosis industry have been compared on the basis of parameters such as revenue and market capitalization.
Bausch Health Companies (Formerly Valeant Pharmaceuticals), Pfizer, Inc., Novartis AG and Johnson & Johnson are some of the key players operating in the US onychomycosis market, whose company profiling has been done in the report. In this segment of the report, business overview, financial overview and business strategies of the companies are provided.
Onychomycosis is a condition of fungal nail infection. Onychomycosis begins in the nail bed and progresses to the nail plate, causing the nail to become discolored, deformed, and even separated from the nail bed. Onychomycosis has a significant chance of reoccurrence. Of all the nail abnormalities in the world, around 50% are the case of onychomycosis. In most of the cases it occurs in the toenails. Onychomycosis is not a life threatening disease but, may persist or worsen if not treated.
Purchase a copy of this report at https://www.marketreportsonline.com/contacts/purchase.php?name=787782.
Symptoms of onychomycosis are changes in appearance of the nail, interference with standing, walking, and exercising, pain, discomfort, etc. The causative pathogens of onychomycosis include dermatophytes (most common), Candida, and nondermatophytic molds.
- Bausch Health Companies (Formerly Valeant Pharmaceuticals)
- Pfizer, Inc.
- Johnson and Johnson
- Novartis AG
There are five types of Onychomycosis: Distal Subungual Onychomycosis, White superficial onychomycosis, Proximal subungual onychomycosis, Endonyx onychomycosis and Candidal onychomycosis. Two types of treatments are available of onychomycosis: Oral Treatment and Topical Treatment. Oral treatment includes: Terbinafine, Itraconazole, etc. and topical treatment includes Kerydin, Jublia, etc. Nonpharmacologic approaches are also there, which includes the following: Laser treatment, Photodynamic therapy, etc.
The US onychomycosis market is forecasted to grow at a healthy growth rate during the forecast period (2019-2023). The US onychomycosis market is supported by various growth drivers, such as rising per capita healthcare expenditure, increasing diabetic patients, ageing population, introduction of new drugs, etc. Yet, the market faces certain challenges, such as, reimbursements, low awareness, side effects, etc.
Inquire more before buying this report at https://www.marketreportsonline.com/contacts/inquirebeforebuying.php?name=787782.
MarketReportsOnline.com is your one stop market research and industry analysis reports’ library providing business data and intelligence information on thousands of micro markets with global as well as regional coverage. Category focused research, country reports, company profiles, regional and global industry profiles and guides to premium reports offering extensive coverage of other 20+ industries are all available in our library of syndicated market research reports.
We provide 24/7 online and offline support to our customers.
E-mail: [email protected] marketreportsonline.com
Phone: +1 888 391 5441